Hatice Odabas - Publications

Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window.

Journal: Current oncology (Toronto, Ont.)

Published: June 18, 2026

Systemic and local dysregulation of the complement system in glioma: a comprehensive systematic review.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 16, 2026

Prognostic Significance of Preoperative PET-CT SUVmax in Resected Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Journal: Medicina (Kaunas, Lithuania)

Published: March 27, 2026

Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: March 04, 2026

Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study.

Journal: BMC cancer

Published: March 02, 2026

Pan-immune-inflammation value as a prognostic and predictive biomarker in metastatic non-small cell lung cancer treated with nivolumab: A real-world study.

Journal: Oncology letters

Published: February 05, 2026

Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk-Stratified Analysis.

Journal: Journal of clinical medicine

Published: January 26, 2026

Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma.

Journal: The Journal of international medical research

Published: January 11, 2026

Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: A Real-World Cohort Study.

Journal: Journal of clinical medicine

Published: January 06, 2026

Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.

Journal: Journal of clinical medicine

Published: December 11, 2025

Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.

Journal: Journal of personalized medicine

Published: December 09, 2025

Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer.

Journal: Journal of clinical medicine

Published: December 05, 2025